SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
4 references·16 citing·36 second hop
Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)Hepatitis B virus testing by minipool nuc…International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)International survey on NAT t…Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence, incidence, and re…Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Infectivity of human immunode…Assessing the impact of HBV NAT on window period reduction and residual risk (2006)Assessing the impact of HBV N…HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)HIV, HCV, and HBV incidence a…Directed Donation: Special Considerations and Review for Contemporary Clinical Practices (2021)Directed Donation: Special Co…Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)Assessing the global burden o…Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)Screening Blood Donors for HI…Direct comparison of three residual risk models for hepatitis B virus window period infections using updated input parameters (2020)Direct comparison of three re…Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003-2017). (2019)Evolution of the residual ris…Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead (2018)Transfusion-Transmitted Infec…Assessment of rapid diagnostic tests and fourth‐generation Enzyme‐Linked Immunosorbent Assays in the screening of Human Immunodeficiency and Hepatitis B virus infections among first‐time blood donors in Libreville (Gabon) (2018)Assessment of rapid diagnosti…Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations (2017)Sensitivity and specificity o…Donor blood screening and moral responsibility: how safe should blood be? (2016)Donor blood screening and mor…Development of a multisystem surveillance database for transfusion‐transmitted infections among blood donors in the United States (2016)Development of a multisystem …Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China. (2015)Seroprevalence of transfusion…Safety of the Blood Supply (2015)Safety of the Blood SupplyTransfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India (2014)Transfusion transmitted infec…The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. (2014)The risk of transfusion-trans…Risk factors for retrovirus and hepatitis virus infections in accepted blood donors (2014)Risk factors for retrovirus a…The Risk of Transfusion-Transmitted Viral Infections (1996)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Blood donor deferral for men who have sex with men: the Blood Donation Rules Opinion Study (Blood DROPS) (2015)Two decades of risk factors and transfusion‐transmissible infections in D utch blood donors (2015)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Standards for blood banks and transfusion services. (1977)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Blood Donation and COVID-19: Reconsidering the 3-Month Deferral Policy for Gay, Bisexual, Transgender, and Other Men Who Have Sex With Men (2020)Follow‐up program for blood donors with unconfirmed screening results reveals a high false‐positive rate in Dalian, China (2020)The Prevalence of Transfusion Transmitted Infections among Blood Donors in Pakistan: A Retrospective Study (2021)Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada (2021)Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases (2023)International review of blood donation nucleic acid amplification testing (2024)Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)Prevention of transfusion-transmitted infections (2019)The BLOODSAFE program: Building the future of access to safe blood in Sub‐Saharan Africa (2022)Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition (2024)Mitigating the impact of blood shortages in England (2024)Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia (2007)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Prevalence of human immunodeficiency virus , hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion‐Transmissible Infections Monitoring System ( TTIMS ) (2020)Civilian walking blood bank emergency preparedness plan (2021)Prevalence and Trends of Major Transfusion Transmissible Infections among Blood Donors in Dire Dawa Blood bank, Eastern Ethiopia: Retrospective Study (1970)Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso (2019)Blood Transfusion-Associated Infections in the Twenty-First Century: New Challenges (2020)
this work references cited by second hop

References

  • 2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
  • 2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
  • 2011International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009191 cited
  • 2006Assessing the impact of HBV NAT on window period reduction and residual risk114 cited

Cited by

  • 2020Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 201678 cited
  • 2021Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions66 cited
  • 2014Risk factors for retrovirus and hepatitis virus infections in accepted blood donors58 cited
  • 2018Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead56 cited
  • 2021HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men52 cited
  • 2014The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre.43 cited
  • 2016Development of a multisystem surveillance database for transfusion‐transmitted infections among blood donors in the United States42 cited
  • 2017Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

39 cited
  • 2019Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003-2017).24 cited
  • 2014Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India19 cited
  • 2015Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China.18 cited
  • 2020Direct comparison of three residual risk models for hepatitis B virus window period infections using updated input parameters14 cited
  • 2016Donor blood screening and moral responsibility: how safe should blood be?12 cited
  • 2015Safety of the Blood Supply12 cited
  • 2021Directed Donation: Special Considerations and Review for Contemporary Clinical Practices11 cited
  • 2018Assessment of rapid diagnostic tests and fourth‐generation Enzyme‐Linked Immunosorbent Assays in the screening of Human Immunodeficiency and Hepatitis B virus infections among first‐time blood donors in Libreville (Gabon)9 cited